On October 17th at 10 AM New York time a select group of investors from America, Europe, Asia and the Middle East will gather on a group-video-call. This exclusive session will focus on healthcare innovations with transformative business potential.

After the opening exchange of insights, participants will take part in a deep dive into SurgiBox — an award-winning company enabling safe surgery at any time, in any place. Their flagship product is an ultra-portable, battery-powered solution that creates sterile surgical conditions, equally suited for private clinics and the most hard-to-reach austere settings, including disaster and conflict zones.

The agenda of the gathering:

• An interactive round table where investors discuss overlooked areas in healthcare with high potential impact
• A live presentation of SurgiBox, its technology, traction, and growth strategy
• A co-development session where investors contribute strategic input and explore synergies with the founding team
• A final round of one-to-one meetings between investors and SurgiBox, as well as with each other, enabling direct follow-ups and alignment

SurgiBox was founded by Harvard Medical School-educated clinicians and incubated at MIT D-Lab. It already has signed distributors in multiple countries, generates revenue, and projects growth to $46M by 2029.

SurgiBox is raising USD $2M SAFE Note through an equity offering of preferred shares with investor-friendly terms with a 20% discount.

Held via video group call on October 17, 2025, the session runs for 2 hours
(6–8 PM Dubai / 10 AM–12 PM New York / 4–6 PM Zurich time).